607-249-4585 Email
Women's Psychiatry, or psychiatric care directed at treating mental health conditions specific to women, is often overlooked as a discipline. However, issues relating to menstruation, contraception, pregnancy, postpartum, and menopause require special consideration of how hormonal fluctuations affect neurochemistry, specifically the relationship between abrupt shifts in hormone levels and proclivity toward depression and anxiety.
In this workshop, we will discuss periods of vulnerability to mood and anxiety disorders as they relate to changes in reproductive hormones, mainly estrogen and progesterone. We will discuss the epidemiology, neuroendocrinology, diagnostic considerations, and impact of mood and anxiety disorders related to the perimenstrual dysphoric disorder, contraception use, postpartum, and menopause. I will introduce clinical cases at the beginning of each didactic module. Participants will work together to conceptualize the cases based on the information presented and their unique clinical perspectives.
CE You!
8.1.23 Women’s Mental Health Throughout the Lifespan
Date of CE Release: 08-01-2023
Date of CE Expiration: 08-01-2024
Location: Online
Accreditation Statement
Physicians
ACCME Credit Designation Statement
Amedco LLC designates this material for a maximum of 3.00 AMA PRA Category 1 Credits TM for physicians. Physicians should
claim only the credit commensurate with the extent of their participation in the activity.
https://ceyouplus.org/workshops/MentalHealth1/view
Women’s Mental Health Throughout the Lifespan
Previously Recorded
Presenter: Esther Rollhaus, MD
Course Length: 3 Hours
This workshop Offers 3 Continuing Education Credits
This webinar is recorded and will not grant live credits.
Women's Psychiatry, or psychiatric care directed at treating mental health conditions specific to women, is often overlooked as a discipline. However, issues relating to menstruation, contraception, pregnancy, postpartum, and menopause require special consideration of how hormonal fluctuations affect neurochemistry, specifically the relationship between abrupt shifts in hormone levels and proclivity toward depression and anxiety.
In this workshop, we will discuss periods of vulnerability to mood and anxiety disorders as they relate to changes in reproductive hormones, mainly estrogen and progesterone. We will discuss the epidemiology, neuroendocrinology, diagnostic considerations, and impact of mood and anxiety disorders related to the perimenstrual dysphoric disorder, contraception use, postpartum, and menopause. I will introduce clinical cases at the beginning of each didactic module. Participants will work together to conceptualize the cases based on the information presented and their unique clinical perspectives.
CE You!
8.1.23 Women’s Mental Health Throughout the Lifespan
Date of CE Release: 08-01-2023
Date of CE Expiration: 08-01-2024
Location: Online
Accreditation Statement
Physicians
ACCME Credit Designation Statement
Amedco LLC designates this material for a maximum of 3.00 AMA PRA Category 1 Credits TM for physicians. Physicians should
claim only the credit commensurate with the extent of their participation in the activity.
(20 minutes) PMDD Case Discussion
2. (20 minutes) PMADs case discussion
3. (20 minutes) Perimenopause- Mood and Anxiety Disorders
(20 minutes) Mood and Anxiety Disorders in Perimenopause case discussion